Pfizer

News

Pfizer axes development of Duchenne muscular dystrophy antib...

Pfizer has axed trials of its domagrozumab antibody for Duchenne muscular dystrophy (DMD), after it failed against efficacy targets.

News

Pfizer drug reduces mortality in patients with fatal heart d...

Pfizer’s heart disease drug, tafamidis, reduces mortality rates in patients, according to the top-line results of a phase 3 trial.

News

Pfizer petitions FDA to clamp down on biosimilar 'scare tact...

Pfizer is calling for the FDA to issue guidance on what originator companies can say about cheaper biosimilars of their products, and prevent them using “scare tactics” to keep doctors pres

News

Merck launches map4health diabetes mobile app

App is result of 11-year collaboration with Healthy Interactions

News

Regeneron/Teva pain drug fasinumab on target in phase 3

Pfizer and Eli Lilly are competitors in NGF research

News

Pfizer invests in mRNA vaccine powerhouse BioNTech

Pfizer is to pay German company BioNTech up to $425m for a multi-year collaboration in the development of more effective influenza vaccines, joining other pharma giants in a promising mRNA-

Pfizer axes development of Duchenne muscular dystrophy antib...

Pfizer drug reduces mortality in patients with fatal heart d...

Pfizer petitions FDA to clamp down on biosimilar 'scare tact...

Merck launches map4health diabetes mobile app

Regeneron/Teva pain drug fasinumab on target in phase 3

Pfizer invests in mRNA vaccine powerhouse BioNTech

ASCO 2026: Quality of life, not just quantity, with Dr Harol...

Discover a new era of healthcare panel engagement: Grounded ...

Pfizer

Editor's Picks